T h e formation of oligomeric structures has been proposed for a large number of membrane proteins, including G-protein-coupled receptors and ion channels. Biochemical studies employing gel filtration, cross-linking or co-immunoprecipitation techniques showed that the serotonin [5-hydroxytryptamine (5-HT)] transporter is also capable of forming oligomers. We investigated whether the human serotonin transporter (hSERT) can be visualized as an oligomer in the plasma membrane of intact cells. T o test this working hypothesis, we generated fusion proteins of hSERT and spectral variants of green fluorescent protein [cyan and yellow fluorescent 
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T h e formation of oligomeric structures has been proposed for a large number of membrane proteins, including G-protein-coupled receptors and ion channels. Biochemical studies employing gel filtration, cross-linking or co-immunoprecipitation techniques showed that the serotonin [5-hydroxytryptamine (5-HT)] transporter is also capable of forming oligomers. We investigated whether the human serotonin transporter (hSERT) can be visualized as an oligomer in the plasma membrane of intact cells. T o test this working hypothesis, we generated fusion proteins of hSERT and spectral variants of green fluorescent protein [cyan and yellow fluorescent proteins (CFP and YFP, respectively)]. When expressed in HeLa or HEK-293 cells, the resulting fusion proteins (CFP-hSERT and YFP-hSERT) were inserted into the plasma membrane and were indistinguishable from wild-type h S E R T on functional testing (5-HT uptake assays, inhibition of 5-HT uptake by blockers such as imipramine). Oligomers were visualized by fluorescence resonance energy transfer (FRET) microscopy in living cells using complementary methods. Interestingly, oligomerization was not confined to hSERT; FRET was also observed between CFPand YFP-labelled rat y-aminobutyric acid transporter. Gel filtration experiments showed that most of the protein was recovered as higher molecular weight complexes; almost no monomeric form was detected. This indicates that the homo-oligomeric form is the favoured state of hSERT in living cells. T h e formation of oligomers was not significantly affected by co-incubation with transporter substrates or blockers. Based on our observations, oligomer formation might not be essential for the physiological function of the transporter protein, the re-uptake of substrates. Furthermore, we conclude that constitutive oligomer formation might be a general property of Na'/Cl--dependent neurotransmitter transporters.
Introduction
T h e serotonin [5-hydroxytryptamine (5-HT)] transporter (SERT) belongs to the family of biogenic amine transporters [l] , a subset of the family of Na'/CI--dependent neurotransmitter transporters that includes the dopamine transporter (DAT) and the norepinephrine (noradrenaline) transporter [2] . T h e main biological function of S E R T is the re-uptake of 5-HT from the neuronal vicinity immediately after its exocytotic release. Therefore, S E R T modulates the concentration of 5 -H T in the synaptic cleft and the time-dependent interaction of 5-HT with both pre-and post-synaptic receptors [3] . Their main physiological function is termination of synaptic transmission ; however, they also transport substrate in reverse [4, 5] . This phenomenon underlies non-vesicular release. Finally, transporters generate inwardly-directed substrate-driven sodium currents in the picoamperic range [6, 7] .
S E R T acts as a target for many therapeutically applied drugs, e.g. the tricyclic antidepressants (e.g. imipramine) and the selective serotonin re-uptake inhibitors (e.g. paroxetine), which are in use for treatment of depression, obsessivecompulsive disorder, and sleep-and eatingdisorders. These re-uptake inhibitors block the substrate-driven physiological functions of SERT. S E R T can be targeted by both clinically important drugs and drugs of abuse, the latter elicit behavioural effects such as drug reward, craving, and depression of appetite and thirst; cocaine and the amphetamines like methylenedioximethamphetamine (ecstasy) serve as examples [8] .
Structural organization of transporter proteins
After the cloning and subsequent structural analysis it was concluded that biogenic amine transporters consist of presumably twelve helices traversing the plasma membrane [9, 10] . However, essential information about the quarternary structure of biogenic amine transporters was lacking.
Over recent years many different methodological attempts have been made to learn more about the structural assembly of transport proteins. Evidence has accumulated to suggest the existence of dimeric or oligomeric structure in transporter proteins like in many other membrane proteins such as tyrosine kinases [ l l ] and G-proteincoupled receptors (GPCRs) [12] . EmrE, a so-called miniTEXAN, the smallest known ioncoupled transporter with four transmembranespanning helices, was described as existing in an oligomeric structure consisting of three associated elements [ 131. Erythrocyte-type glucose transporters (GLUT-1 and GLUT-4) have been shown to form homo-oligomeric, but not heterooligomeric, structures by co-immunoprecipitation; the authors used an elegant approach of domain swapping resulting in the creation of intersubtype chimeras (GLUT-1 was rearranged with GLUT-4) [14] . By application of cross-linking methods, the possibility of there being oligomeric structures in different rat brain glutamate transporters was demonstrated [15] . This notion was extended by Eskandari et al. who used freeze-fracture electron microscopy to show the pentameric assembly of the neuronal glutamate transporter EAAT3 [16] . Among the biogenic amine transporters, rat D A T was proposed to exist as an oligomer. Radiation inactivation showed that the molecular mass of the target size was twice what was expected. This observation led the authors to the conclusion that D A T forms a homo-oligomer or hetero-oligomer in situ [17] . By applying a similar methodology, these conclusions were also drawn for S E R T [18] . In addition, recent experiments provide additional biochemical evidence for the possible existence of quaternary structures in SERT. This has been shown for rat S E R T by cross-linking studies [ 191. T h e concatenated mouse S E R T ('head-to-tail' concatenates of up to four copies) has been shown to be functional [20] . T h e first approximation to any impact of oligomerization of S E R T for its function was provided by Kilic and Rudnick [21] in a co-immunoprecipitation study that employed two differently epitope-tagged SERTs, one sensitive to inactivation, the other resistant to it. By measuring how transport activity is affected by the homoassociation of SERT, the authors concluded that S E R T existed as a functional oligomer, presumably organized in a tetrameric structure.
The principle of fluorescence resonance energy transfer (FRET)
Apart from these invasive and destructive biochemical or physical approaches, a method has been introduced recently that allows one to monitor the dynamic association of proteins in living cells. This approach relies on FRET. F R E T is a phenomenon which only occurs if two fluorophores are in sufficient proximity ( < 100 A) and in an appropriate relative orientation allowing an
excited fluorophore (donor) to transfer its energy to a second, longer-wavelength fluorophore (acceptor) in a non-radiative manner [22] . T h e excitation of the donor can produce light emission from the acceptor, with substantial loss of emission from the donor.
If a fluorophore absorbs light it moves from a ground state (SO) to a higher vibrational level in the excited state (S2). On returning to the energetically more favourable SO state, the fluorophore emits energy in the form of a photon (fluorescence), the wavelength of which is longer than the excitation wavelength. If a second fluorophore, whose maximum of excitation in the wavelength range of the donor emission, is in close proximity to the emitting fluorophore, it gets transformed into the excited state. This leads to the emission of photons of the acceptor-specific wavelength. This emission occurs by a direct transfer of energy from the donor to the acceptor fluorophore and does not require the emission of photons by the donor. It represents a quantum mechanical phenomenon mediated by a longrange dipole-dipole interaction between donor and acceptor fluorophore, which results in a decrease of the donor emission and an increase in acceptor fluorescence. This phenomenon was first described in the late 1940s by Forster [23] , who showed that energy can be transferred directly from a donor fluorophore to a non-identical acceptor fluorophore by a process [24] that does not require a mechanical collision to occur and that does not produce heat or radiation [25] .
Requirements for F R E T include a substantial overlap of the emission spectra of the donor with the absorption spectra of the acceptor; the proteins under study must be some way aligned to give way for dipoledipole interactions and the distance between the two fluorophores must fall within the appropriate range of energy transfer. F R E T intensity is lost to the sixth power of distance. Therefore, the maximum distance for F R E T for most donor-acceptor pairs is calculated as being less than l o o & which makes it suitable for investigating tight molecular interactions.
Because F R E T is a non-destructive spectroscopic method, it can be performed in living cells. A major obstacle to implementation of F R E T microscopy in living cells has been the lack of suitable methods for labelling intracellular proteins with appropriate fluorophores. This has been resolved by the molecular cloning of the jellyfish green fluorescent protein (GFP) by Prasher et al. [26] . Subsequently, after the recog-0 200 I Biochemical Society nition of the versatility of this new labelling method, major contributions by several groups led to improved intensity of green light emission (e.g. enhanced GFP) [27] . Introduction of mutations involving several single amino acid changes produced new interesting spectral variants, including blue, cyan and yellow emitting fluorescent proteins [28] . In living cells the fluorophores are created by transient or stable transfection of appropriate plasmids, in which the coding sequences for the proteins of interest are fused to several mutated G F P coding sequences. T h e principles of the strategy presented here have been reviewed in detail by Pollok and Heim [29] .
FRET as a tool for measuring oligomerization
This novel strategy has already been applied successfully for several GPCRs, such as the somatostatin or the S-opioid receptors [30,3 13. We initiated a study of the oligomerization of S E R T in living cells. S E R T was tagged with two different spectral G F P variants [yellow fluorescent protein (YFP) and cyan fluorescent protein (CFP)], the fluorescent tag being linked to the NH,-terminus of the transporter, which resides on the cytoplasmic side of the cellular membrane. We assessed their function by conducting a series of preliminary uptake experiments. Cells transfected only with fluorescent protein-vectors do not take up radiolabelled 5-HT specifically ; more importantly, there was no difference in transport between the fluorescently tagged S E R T chimeras and wildtype S E R T itself. Furthermore, inhibition of uptake was achieved using imipramine, a tricyclic antidepressant, yielding nearly identical IC, , , values [32] .
We validated the suitability of F R E T as an approach to study protein-protein interactions in transporters by a series of preliminary experiments. First, we transfected the YFP and C F P vectors transiently into human embryonic kidney-293 cells (HEK-293), using the calcium phosphate precipitation method ; these served as the negative control. Fluorescence microscopy was conducted with either the C F P filter set (excitation, 440f 10 nm; dichroic mirror, 455 nm; emission, 480f 15 nm) or the YFP tilter set (excitation, 500 f 12 nm ; dichroic mirror, 525 nm ; emission, 535 17 nm). T h e fluorescence \VRS evenly distributed over the cells as would be expected for a cytosolic protein that is also small enough to enter the nucleus via passive diffusion. T h e picture taken with the YFP filter set was virtually identical. When filters were switched to the F R E T wavelength (excitation, 440f 10 nm; dichroic mirror, 455 nm; emission, 535 f 13 nm), and images were taken with the same charge-coupled-device camera settings as applied for the C F P filter, the emission was lower. Division of the F R E T filter derived image by the picture acquired with the C F P filter, using the mathematical algorithm of the National Institutes of Health Image Software, resulted in a black ratio image. This is in line with data obtained by quantitative scanning fluorometry for the CFP/YFP pair, indicating that no energy transfer occurs between these two proteins. Even under the assumption that two different fluorescent proteins do collide stochastically in a cell, this collision obviously is not sufficient to support FRET.
T o obtain a positive control, we established a construct containing the YFP and C F P sequences linked together by a short cleavable linker sequence. Given the known Forster distance for C F P and YFP of -50 A and the small distance between C F P and YFP in the chimeric construct, a strong intramolecular F R E T signal has to be expected. T h e experimental data obtained showed that this was the case. Establishing a ratio image of the pictures taken under CFP-and FRET-filter conditions clearly shows an intense F R E T signal with cytosolic localization. This finding was to be expected for the CFP-YFP chimeric construct. T h e F R E T imaging results were also verified by fluorimetric wavelength scanning, showing a distinct increase of acceptor emission [32] .
T o investigate a putative oligomerization of human S E R T (hSERT) using an intermolecular FRET, we used the CFP-and YFP-fusion proteins of hSERT. Co-transfection of the two differently tagged transporter chimeras in HEK-293 or HeLa cells was performed either using the calcium phosphate method or Lipofectamine Plusmg. We observed bright fluorescence when exciting with the YFP filter set, with a distinct localization at the cellular membrane. In addition, in cells that strongly overexpressed the proteins, a perinuclear Golgi-like stain was visible. Fluorescence emitted by C F P at its maximum excitation peak was obviously lower, a first indication of a loss of photonic energy due to FRET. Imaging with the F R E T filter set resulted in a higher intensity than with C F P excitation alone. After application of the mathematical algorithm for calculation of the ratio image, a considerable amount of fluorescence remained in the cell mem-brane; this is unequivocal evidence for F R E T In order to validate the approach with the technique of ratio-imaging FRET-microscopy, we applied two complementary FRET-methodologies : (i) donor-recovery after acceptor photobleaching FRET-microscopy, and (ii) donor-photobleaching FRET-microscopy. Both methods rely on the fact that the spectroscopic properties of the hSERT-fluorescent protein chimeras change significantly when one of the corresponding F R E T partners is excluded from the energy transfer by nearly selective bleaching using a strong light-source over a certain time. In the case of donor-recovery after acceptor photobleaching FRET-microscopy, the acceptor (YFP) will be bleached to lOoi, of its basal value. When comparing pictures of CFP-hSERT-transfected cells before and after acceptor bleaching, an increase in fluorescence emission of CFPhSERT after acceptor bleaching is indicative of a positive FRET, since all the energy is then available for the excitation of CFP, and none of it will be transferred on to YFP. Donorphotobleaching FRET-microscopy is explained by an increase in the time it needs to bleach the donor of a F R E T pair since the energy transfer withdraws the energy normally forcing the bleaching of the donor molecule. In the case of the hSERT-fluorescent protein chimeras, both techniques clearly indicated positive FRET.
T h e next question was to evaluate the impact exerted by substrates of S E R T or transport inhibitors on the oligomeric state of SERT. We applied substrates such as 5-HT, methyl-phenylpyridinium and amphetamine derivatives like parachloroamphetamine or D-fenflUramine. Uptake inhibitors like cocaine, imipramine, paroxetine or citalopram were also used at concentrations that were 10-fold greater than the IC,, values for inhibition of uptake. Neither substrates nor uptake inhibitors led to changes in the intensity of the fluorescent signal emitted by the coupling of the F R E T pairs as measured with all three complementary F R E T microscopy methods. Considering the observations described above, we concluded that the substances, as powerful as they are in blocking uptake or induction of release, do not interfere with oligomerization as measured with the SERT-fluorescent protein chimeras in living cells [32] .
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